Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Angewandte Chemie (International Ed. in English)|December 16, 2025
Synergy of Nickel Single-Atom and Heteroatoms Co-Doping in Carbon for Efficient Hydrogen Peroxide ElectrosynthesisChunxiao Liu, Kangjuan Cheng, Qiuxu Chen, et al.Journal of Experimental & Clinical Cancer Research : CR|September 5, 2018
Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expressionShaoying Yan, Zhenrong Tang, Ke Chen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2026
Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 TrialDavid Alexanderian, Fabiano Ramos, Soumya Chatterjee, et al.Journal of Cellular Physiology|February 12, 2019
LINC00628 suppresses migration and invasion of hepatocellular carcinoma by its conserved region interacting with the promoter of VEGFAQiuxu Chen, Dan Wang, Yongguo Li, et al.Gene|August 12, 2018
LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinomaShaoying Yan, Xuefeng Shan, Ke Chen, et al.Oncotarget|October 4, 2017
LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5pLiying Zhu, Nenghong Yang, Juan Chen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.Vaccine|April 27, 2023
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)Federico Martinon-Torres, Jacek Wysocki, Leszek Szenborn, et al.Nature Medicine|March 4, 2026
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccineEsper G Kallás, José A Moreira, Elizabeth G Patiño, et al.Pageof 2